City Therapeutics Announces Closing of $230.0 Million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
City Therapeutics (CTY) Debuts Strongly But Fair Value Remains Hard To Pin Down
City Therapeutics (CTY) Filed A $239.1 Million Shelf Registration After Its IPO
City Therapeutics surges in market debut after upsizing $200M IPO
City Therapeutics Announces Pricing of Upsized Initial Public Offering
City Therapeutics, RNAi Treatment Developer, Files For IPO
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
